| Market Cap | ₹40Cr |
| ROE | 3.48% |
| P/E Ratio(TTM) | 40.63 |
| EPS(TTM) | 0.41 |
| P/B Ratio | 1.04 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.32 |
| Book Value | 16.01 |
| Debt to Equity | 0.23 |
| Face Value | 10 |
| Parent Organisation | Dipna Pharmachem Ltd |
| Managing Director | Keyur Dipakkumar Shah |
| BSE Symbol | 543594 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.61 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.73 | ||
| Cohance Lifesciences | NA (0.00%) | 68.91 | ||
| Wockhardt | NA (0.00%) | -392.85 |